By: Chang Ming-hsuan and Chung Yu-chen
Taipei, Dec. 17 (CNA) A total of 1 million diabetes drugs manufactured by Taiwan's pharmaceutical company Standard Chem. & Pharm. CO., LTD are being recalled because they are alleged to contain extraneousmaterial, according to the Taiwan Food and Drug Administration (FDA) on Thursday.
The recall involves two types of drugs, Metformin 500 (batch number: TL092117) and Metformin 850 (batch number: TL180260), which were alleged to contain extraneous material made of fiber, the administration said.
Metformin 500 and Metformin 850, which together comprise a 20 percent market share for this type of drug, are frequently used by diabetic patients, said Hung Kuo-teng (洪國登), head of the FDA's Medicinal Products Division, at a telephone interview with reporters on Thursday.
As to what exactly the drugs were found to contain, Hung said the Tainan City-based company is now looking into the case and is required to submit an investigative report at the end of this December. [FULL STORY]